New Study Shows Aspirin can Dramatically Reduce Death by Cancer

New research suggests that long-term use of a daily low-dose aspirin can exponentially decrease the risk of dying from a wide array of cancers. In the report, coming from eight long term studies including some 25,000 patients, British researchers found that a small, 75 milligram dose of aspirin taken daily for at least five years reduces risk of dying from common cancers roughly 10 to 60 percent. The findings are as follows:

• After 5 years of daily aspirin, death due to gastrointestinal cancers decreased by 54%.
• After 20 years, death due to prostate cancer decreased by 10%
• After 20 years, death due to lung cancer decreased by 30% (among those with adenocarcinomas, typically seen in nonsmokers)
• After 20 years, death due to colorectal cancer decreased by 40%
• After 20 years, death due to esophageal cancer decreased by 60%

While this is great news for those who suffer from cancers, Professor Peter Rothwell of the University of Oxford and John Radcliffe Hospital says a daily aspirin regimen can cause complications such as bleeding. Still, it is surprising to know such an affective drug can easily be found in any household.

Source[Yahoo!News]